Ad
Friday, 9 February 2018
Roche wins UK watchdog's nod for lymphoma drug after initial snub
ZURICH (Reuters) - Britain's healthcare watchdog (NICE) recommended Roche's medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker's medicine last year as too expensive.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment